Pilot Production of the Institute of Bioorganic Chemistry

http://www.hopiboh.org/  

Drug for syphilis diagnosis

COUNTRY OF ORIGIN

IDENTIFIER

BO3668

PUBLISHED

2021-04-09

LAST UPDATE

2021-04-12

DEADLINE

Linked profile in other language
Responsible
Dmitrii Ianushevskii
hopmang@adsl.by
Summary
The Unitary Enterprise "Pilot Production of the Institute of Bioorganic Chemistry National Academy of Sciences of Belarus" offers consumers and distributors Drug for syphilis diagnosis under a manufacturing or distribution agreement.
Description
The for syphilis diagnosis - Cardiolipin antigen for the microprecipitation reaction (ACRM) is intended for the microprecipitation reaction - the detection of antibodies to the causative agent of syphilis in plasma or inactivated human serum.

The AKRM diagnosticum includes the following components:
* cardiolipin antigen, 10 ampoules, 2 ml each;
* 70% choline chloride solution, 2 vials of 5 ml.

Diagnosticum AKRM is designed for 1000 determinations.

The purpose, characteristics, and instructions of the drug can be found here
Advantages and Innovations
Indicated on the company's website
Stage of development
Already on the market
Funding source
State budged
Internal
IPR status
Exclusive rights
Secret know-how
Sector group
BioChemTech
Healthcare

Organization information

Type
Industry SME 50-249
Year established
1986
NACE keywords
M.72.19 - Other research and experimental development on natural sciences and engineering
Q.86.90 - Other human health activities
Turnover (in EUR)
10-20M
Already engaged in transnational cooperation
Yes
Additional comments
The enterprise has distributors in Russia and Ukraine.
Certification standards
The enterprise has implemented a quality management system for the production of diagnostic kits for in vitro diagnostics. In 2012, the company's quality management system was certified for compliance with the requirements of STB ISO 9001-2009 (certificate of conformity STB No. BY / 112 05 01.002 02704). In 2017, the company's quality management system was certified for compliance with the requirements of the international standard EN ISO 13485: 2012 (certificate No. 9124.IBCN).
Languages spoken
English
Russian

Information about partnership

Type of partnership considered
Distribution services agreement
Manufacturing agreement
Type and role of partner sought
Consumers interested in purchasing Drugs for syphilis diagnosis under a manufacturing agreement.

Distributors interested in purchasing Drugs for syphilis diagnosis under a distribution agreement.
Type and size of partner sought
> 500
251-500
SME 51-250
SME 11-50
SME <= 10
R&D Institution

Attachments

Views: 1672
Statistics since 11.04.2021 23:40:39